Echinokokkosen der Leber

D. Henne-Bruns; T. F. Barth; T. Gräter; A. Hillenbrand; W. Kratzer; J. Schmidberger; B. Grüner

doi:10.1055/s-0042-110842

Allgemein- und Viszeralchirurgie up2date, Table of Contents

Allgemein- und Viszeralchirurgie up2date 2016; 10(05): 369-394
DOI: 10.1055/s-0042-110842

Leber, Galle, Pankreas, Milz

Georg Thieme Verlag KG Stuttgart · New York

Echinokokkosen der Leber

D. Henne-Bruns

¹Klinik für Allgemein- und Viszeralchirurgie, Universitätsklinikum Ulm

,

T. F. Barth

⁵Institut für Pathologie, Universitätsklinikum Ulm

,

T. Gräter

⁴Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Ulm

,

A. Hillenbrand

¹Klinik für Allgemein- und Viszeralchirurgie, Universitätsklinikum Ulm

,

W. Kratzer

³Klinik für Innere Medizin I, Universitätsklinikum Ulm

,

J. Schmidberger

³Klinik für Innere Medizin I, Universitätsklinikum Ulm

,

B. Grüner

²Klinik für Innere Medizin III, Universitätsklinikum Ulm

› Author Affiliations

Abstract

All articles of this category

Die Echinokokkosen des Menschen sind Zoonosen als Folge einer Infektion mit den Larvenstadien der Gattung Echinococcus, bei denen der Mensch als Fehlzwischenwirt fungiert. Für Mitteleuropa bzw. Deutschland humanmedizinisch relevant sind

• die zystische Echinokokkose – Hundebandwurmerkrankung, verursacht durch Echinococcus granulosus – und

• die alveoläre Echinokokkose – Fuchsbandwurmerkrankung, verursacht durch Echinococcus multilocularis.

Da das Wachstumsverhalten der beiden Spezies im Menschen sehr unterschiedlich ist, resultieren 2 in Diagnostik, Therapie und Prognose verschiedene Erkrankungen, weswegen die beiden Krankheitsbilder hier separat vorgestellt werden sollen.

Full Text

References

Literatur
1 Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107-135
2 Robert Koch-Institut. Epidemiologisches Bulletin: Echinokokkose. Berlin: RKI; 2005
3 Romig T. Epidemiology of echinococcosis. Langenbecks Arch Surg 2003; 4: 209-217
4 Romig T, Kratzer W, Kimmig P. An epidemiological survey of human alveolar echinococcosis in southwestern Germany. Am J Trop Med Hyg 1999; 61: 566-773
5 Torgerson P, Keller K, Magnotta M et al. The global burden of alveolar echinococcosis. PLoS Negl Trop Dis 2010; 4: e722
6 Craig P. Epidemiology of human alveolar echinococcosis in China. Parasitol Int 2005; 55 (Suppl. 01) S221-S225
7 Robert Koch-Institut. SurvStat@RKI 2.0: Alveoläre und Zystische Echinokokkose in Deutschland 2015. Im Internet: http://www.survstat.rki.de/Content/Query/Create.aspx Stand: September 2016
8 Nothdurft H, Jelinek T, Mai A et al. Epidemiologie der Echinokokkose in Bayern. Dtsch Med Wochenschr 1995; 120: 1151-1155
9 Eckert J. The “dangerous fox tapeworm” (Echinococcus multilocularis) and alveolar echinococcosis of humans in central Europe. Berl Münch Tierärztl Wochenschr 1996; 109: 202-210
10 Piarroux M, Piarroux R, Knapp J et al. Populations at risk for alveolar echinococcosis, France. Emerg Infect Dis 2013; 19: 721-728
11 Kern P, Bardonnet K, Renner E et al. European Echinococcosis Registry: Human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis 2003; 9: 343-349
12 Ammann RW. Cestodes. Echinococcus. Gastroenterol Clin North Am 1996; 25: 655
13 Pawlowski Z, Eckert J, Vuitton D. WHO/OIE Manual on echinococcosis in humans and animals: a public health problem of global concern: Echinococcosis in humans: clinical aspects, diagnosis and treatment. Im Internet: http://apps.who.int/iris/bitstream/10665/42427/1/929044522X.pdf Stand: September 2016
14 Reuter S, Seitz HM, Kern P et al. Extrahepatic alveolar echinococcosis without liver involvement: a rare manifestation. Infection 2000; 28: 187-192
15 Bresson-Hadni S, Laplante J, Lenys D et al. Seroepidemiologic screening of Echinococcus multilocularis infection in an European area endemic for alveolar echinococcosis. Am J Trop Med Hyg 1994; 51: 837
16 Kern P. Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 2010; 23: 505-512
17 Piarroux M, Piarroux R, Giorgi R et al. Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: Results of a survey in 387 patients. J Hepatol 2011; 55: 1025-1033
18 Brunetti E, Kern P, Vuitton D. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Tropica 2009; 114: 1-16
19 Kern P, Kurz S, Beurton I et al. Alveoläre Echinokokkose. Entwicklung und Vorschlag einer klinischen Klassifikation in Anlehnung an das TNM-System. Chemother J 2002; 11: 151-153
20 Kern P, Wen H, Sato N et al. WHO classification of alveolar echinococcosis: Principles and application. Parasitol Int 2005; 55: S283-S287
21 Frosch M. Labordiagnose der zystischen und alveolären Echinokokkose. J Lab Med 2003;
22 Reiter-Owona I, Grüner B, Frosch M et al. Serological confirmatory testing of alveolar and cystic echinococcosis in clinical practice: results of a comparative study with commercialized and in-house assays. Clin Lab 2009; 55: 41-48
23 Kratzer W, Grüner B, Kaltenbach T et al. Proposal of an ultrasonographic classification for hepatic alveolar echinococcosis: Echinococcosis multilocularis Ulm classification – ultrasound. World J Gastroenterol 2015; 21: 12392-12402
24 Graeter T, Kratzer W, Oeztuerk S et al. Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World J Gastroenterol 2016; 22: 3621-3631
25 Vuitton D, Bresson-Hadni S. Alveolar echinococcosis: Evaluation of therapeutic strategies. Expert Opinion on Orphan Drugs 2014; 2: 67-86
26 Vuitton D. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: What is the consensus?. Expert Rev Anti-Infect Ther 2014; 7: 145-149
27 Reuter S, Buck A, Manfras B et al. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology 2004; 39: 509-517
28 Reuter S, Gruener B, Buck A et al. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Nuklearmedizin 2008; 4: 139-177
29 Ammann R, Stumpe KDM, Grimm F et al. Outcome after discontinuing long-term benzimidazole treatment in 11 patients with non-resectable alveolar echinococcosis with negative FDG-PET/CT and anti-EmII/3-10 serology. PLoS Negl Trop Dis 2015; 9: e0003964
30 Kadry Z, Renner EC, Bachmann LM et al. Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis. Br J Surg 2005; 92: 1110-1116
31 Brunetti E, Kern P, Vuitton D. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Tropica 2009; 114: 1-16
32 Buttenschoen K, Kern P, Reuter S et al. Hepatic infestation of Echinococcus multilocularis with extension to regional lymph nodes. Langenbecks Arch Surg 2009; 394: 699-704
33 Torgerson P, Macpherson C. The socioeconomic burden of parasitic zoonoses: global trends. Vet Parasitol 2011; 182: 79-95
34 Tappe D, Zidowitz S, Demmer P et al. Three-dimensional reconstruction of echinococcus multilocularis larval growth in human hepatic tissue reveals complex growth patterns. Am J Tropical Med Hyg 2010; 82: 126-127
35 Barth T, Herrmann T, Tappe D et al. Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11. PLoS Negl Trop Dis 2012; 6: e1877
36 Torgerson P, Schweiger A, Deplazes P et al. Alveolar echinococcosis: From a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 2008; 49: 72-77
37 Bresson-Hadni S, Koch S, Miguet J et al. Indications and results of liver transplantation for Echinococcus alveolar infection: an overview. Langenbecks Arch Surg 2003; 388: 231-238
38 Chauchet A, Grenouillet F, Knapp J et al. Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions. Clin Infect Dis 2014; 59: 1095-1104
39 Conchedda M, Antonelli A, Caddori A et al. A retrospective analysis of human cystic echinococcosis in Sardinia (Italy), an endemic Mediterranean region, from 2001 to 2005. Parasitol Int 2010; 59: 454-459
40 Eckert J, Schantz P, Gasser R et al. Geographic Distribution and Prevalence. In: Eckert J, Gemmell MA, Meslin FX, Pawłowski ZS, eds. WHO/OIE Manual on Echinococcosis in Humans and Animals: a public Health Problem of global Concern. Paris: WHO; 2001: 100-142
41 Caremani M, Maestrini R, Occhini U et al. Echographic epidemiology of cystic hydatid disease in Italy. Eur J Epidemiol 1993; 9: 401-404
42 Frider B, Larrieu E, Odriozola M. Long-term outcome of asymptomatic liver hydatidosis. J Hepatol 1999; 30: 228-231
43 Tabain I, Sviben M, Ljubin-Sternak S et al. Seroprevalence of echinococcus granulosus infection in Croatian patients with cystic liver disease. J Helminthol 2011; 85: 192-195
44 Macpherson C, Milner R. Performance characteristics and quality control of community based ultrasound surveys for cystic and alveolar echinococcosis. Acta Tropica 2003; 85: 203-209
45 Larssen TB, Rørvik J, Hoff SR et al. The occurrence of asymptomatic and symptomatic simple hepatic cysts. A prospective, hospital-based study. Clin Radiol 2005; 60: 1026-1029
46 Liang P, Cao B, Wang Y et al. Differential diagnosis of hepatic cystic lesions with gray-scale and color Doppler sonography. J Clin Ultrasound 2005; 33: 100-105
47 Kilimcioğlu A, Özkol M, Bayındır P et al. The value of ultrasonography alone in screening surveys of cystic echinococcosis in children in Turkey. Parasitol Int 2006; 55: 273-275
48 Junghanss T, da Silva A, Horton J et al. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg 2008; 79: 301-311
49 Menezes da Silva A. Hydatid cyst of the liver – criteria for the selection of appropriate treatment. Acta Tropica 2003; 85: 237-242
50 Kodama Y, Fujita N, Shimizu T et al. Alveolar echinococcosis: MR findings in the liver. Radiology 2003; 228: 172-177